Journal of Antimicrobial Chemotherapy (2000) 46, 847-848
© 2000 The British Society for Antimicrobial Chemotherapy
Correspondence |
Quinolone-induced QT interval prolongation: a not-so-unexpected class effect
Infectious Disease Research, Ortho-McNeil Pharmaceutical, 1000 Route 202, Box 300, Raritan, NJ 08869-0602, USA
Sir,
I read with great interest Dr Peter Ball's recent leading article on quinolone-induced QT interval prolongation.1 The author's re-examination of the facts is an admirable effort to discuss recently highlighted fluoroquinolone safety issues. While agreeing that well-studied, and generally safe, antibiotics should be used for the treatment of infections, regardless of minor QT prolongation effects, I do not agree that this cardiac effect is established as a fluoroquinolone
Notes
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Rubinstein and J. Camm Cardiotoxicity of fluoroquinolones J. Antimicrob. Chemother., April 1, 2002; 49(4): 593 - 596. [Full Text] [PDF] |
||||
![]() |
P. B. Iannini Quinolone-induced QT interval prolongation: a not-so-unexpected class effect J. Antimicrob. Chemother., June 1, 2001; 47(6): 893 - 894. [Full Text] [PDF] |
||||
